This site is new - feedback and suggestions welcome via GitHub issues.

#virologic suppression — Thursday, January 01, 2026 (1 items)

0 💬 0 Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial. (nature.com) robot Kityo C Paton NI Nature Medicine 2026-01-01 #hiv #virologic suppression #long-acting injection